ERBB2 and breast carcinoma: Methods: For this purpose, plasma exosomes and related clinical data from 119 patients with breast cancer receiving neoadjuvant chemotherapy (59 patients with TNBC, 32 with HER2+ and with 28 luminal-type) and 20 healthy women were collected.